BMI vs MSFT

The Advanced Deterministic Scorecard shows a weak Piotroski F-Score of 4/9, indicating marginal financial health, and the absence of an Altman Z-Score prevents a full solvency risk assessment. Despite solid profitability metrics like 21.45% ROE and 19.57% operating margin, elevated valuation (P/E of 36.77 vs. sector average of 84.87) and bearish technical trend (0/100) offset strength in fundamentals. Revenue and earnings growth remain positive at 13.1% and 10.2% YoY, but recent price performance is sharply negative (-22% over 1Y), and analyst target suggests upside to $211.30. The stock trades well above the Graham Number of $49.73, reflecting premium pricing for growth expectations despite mixed earnings surprise trends.

Microsoft exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust financial stability. While the stock is currently experiencing a severe technical downtrend (0/100) and significant 6-month price depreciation (-28.6%), the current price of $374.33 sits well below the growth-based intrinsic value of $471.41 and the analyst target of $587.31. Exceptional earnings growth (59.8% YoY) and high operating margins (47.09%) suggest that the current price correction presents a value opportunity despite bearish insider sentiment.